Home / DoD / GAO: US Biodefense Enterprise Needs Central Leadership, Oversight

GAO: US Biodefense Enterprise Needs Central Leadership, Oversight

biohazardThe Government Accountability Office has said in a new report to the Senate Homeland Security Committee that the U.S. biodefense enterprise needs an established leadership strategy.

GAO said in the report published Thursday it found that there is no unifying biodefense leadership and oversight structure to facilitate accountability and operational efficiency.

The agency said past reports from GAO and other review bodies called for the establishment of a focal point for government biodefense coordination and the formation of a national strategy that will work to identify and address risks systematically.

Biosurveillance efforts also need a national strategy as GAO previously recommended a central leadership and action to address various challenges, GAO noted.

GAO further said increased threats of disease outbreak and acts of bioterrorism, such as anthrax attacks, reflect a need for early detection and warning through biosurveillance systems.

Check Also

GAO: Air Force to Deploy New Combat Rescue Helicopters to Active Component by FY 2020

The Government Accountability Office has found that the U.S. Air Force intends to start fielding in fiscal 2020 new Combat Rescue Helicopters to replace aging HH-60G Pave Hawk helicopters that have recorded the most flight time when it comes to staff recovery missions. GAO said in a report published Thursday the service will initially deploy the new helicopters to the active component six years ahead of the reserve component and to the Air National Guard by 2027.

Leave a Reply

Your email address will not be published. Required fields are marked *